Heart Protection In large-scale clinical trials like LEADER, GLP-1s were shown to lower the risk of heart attack, stroke, and cardiovascular death
To this end, RGA developed a model to assess the potential impact of these drugs as treatments for weight loss in obese populations, and for diabetes on population mortality and morbidity, revealing significant potential reductions in cardiovascular incidence and mortality rates
Ventricular tachycardia Known hypersensitivity Side Effects: Headache, reflex bradycardia, excitability, restlessness, and rarely arrhythmias Pharmacokinetics: To be effective, phenylephrine should be given by nasal spray, s.c., i.m
This drug has sedating and anti- cholinergic (suppression of urge to urinate) effects
Para ello, acta como un agonista, una sustancia que imita a la hormona natural mediante la unin a los mismos receptores celulares en el cerebro y produce una respuesta similar o aumentada en el organismo, lo que incluye mayor liberacin de insulina, disminucin del apetito y digestin lenta
If its 500 mcg/mL, 1,000 mcg is 2 mL
